Harnessing AI for the Future of Pharma Manufacturing
Clicks: 25
ID: 311267
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
7.2
/100
25 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #9 of 34 articles by views in Journal of Clinical Advances and Research Reviews
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Artificial Intelligence (AI) is making significant changes in numerous healthcare sectors around the world. Being an essential component of healthcare, the pharmaceutical industry is also not behind in utilizing AI’s vital role at various phases of the drug development process. Specifically, AI can be utilized at various stages of pharmaceutical research and manufacturing starting from drug discovery to several tasks involved in manufacturing operations ranging from quality control to packaging, including product tracking from beginning to end. AI plays a vital role in enhancing the complex manufacturing of biopharmaceuticals by optimizing processes in real time, monitoring cell health, and employing predictive analytics. By improving visibility, efficiency, and compliance, AI can lead to smarter manufacturing processes, superior quality products and efficient supply chain solutions. In addition, AI has a critical role to play in achieving temperature-controlled distribution of biopharmaceuticals, supply chain management, prediction of potential issues and patient-focused solution creations helpful in personalized medicine. However, there are still several challenges that need to be addressed before fully integrating AI into manufacturing operations at all levels. This article reviews the potential of AI in pharmaceutical manufacturing, highlighting its benefits, recent breakthroughs and major challenges in its full implementation. The article also discusses the prospects of AI and suggests solutions to overcome real time limitations associated with full implementation of an AI-integrated pharmaceutical manufacturing and research efforts within the industry and academic settings.
| Reference Key |
imported_1770374242_6985c462e38fd
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Archana Pattanaik*, Souvik Giri, Debashish Mohanty, Nilima Shukla |
| Journal | Journal of Clinical Advances and Research Reviews |
| Year | 2025 |
| DOI |
10.62896/jcarr.v2.i1.04
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.